Space group symmetries of the phases of (Pb0.94Sr0.06)(ZrxTi1-x)O3 across the antiferrodistortive phase transition in the composition range 0.620<x<0.940
Ravindra Singh Solanki, Anatoliy Senyshyn, and Dhananjai Pandey

TL;DR
This study clarifies the space group symmetries of Pb(ZrxTi1-x)O3 across the antiferrodistortive transition, resolving controversies with detailed diffraction analysis and proposing a comprehensive phase diagram for compositions 0.40<x<0.90.
Contribution
It provides definitive symmetry assignments for phases in PSZT near the AFD transition, using combined diffraction and dielectric measurements, and refines the phase diagram for these compositions.
Findings
Rietveld analysis rejects rhombohedral phases above and below TAFD.
Monoclinic symmetries Cc and Cm are confirmed below and above TAFD.
A phase diagram for 0.40<x<0.90 is proposed, showing stability fields of various phases.
Abstract
The existing controversies about the space group symmetries of Pb(ZrxTi1-x)O3 (PZT) above and below antiferrodistortive (AFD) phase transition temperature (TAFD) in the Zr4+- rich (0.620<x<0.940) compositions are addressed using the results of dielectric, synchrotron x-ray powder diffraction (SXRPD) and neutron powder diffraction (NPD) studies. These compositions undergo an AFD phase transition above room temperature due to tilting of oxygen octahedral leading to a superlattice phase of PZT. We have substituted 6% Sr2+ at Pb2+-site to enhance the tilt angle and thereby the intensity of the superlattice peaks. The real and imaginary parts of complex dielectric permittivity have been used to locate the paraelectric to ferroelectric and ferroelectric to AFD phase transitions. Rietveld analysis of SXRPD and NPD profiles unambiguously reject the rhombohedral phases in R3c and R3m space…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
